Bacterial Vaginosis - Pipeline Review, H1 2017 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Bacterial Vaginosis - Pipeline Review, H1 2017" report to their offering.

This report provides comprehensive information on the therapeutic development for Bacterial Vaginosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Bacterial Vaginosis and special features on late-stage and discontinued projects.

Bacterial vaginosis (BV), also known as vaginal bacteriosis is a type of vaginal inflammation caused by overgrowth of bacteria present in vagina. Symptoms include vaginal itching; burning during urination and vaginal discharge may become watery and thin. Treatment includes antibiotics.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Bacterial Vaginosis Overview
  3. Therapeutics Development
  4. Pipeline Products for Bacterial Vaginosis - Overview
  5. Pipeline Products for Bacterial Vaginosis - Comparative Analysis
  6. Bacterial Vaginosis - Therapeutics under Development by Companies
  7. Bacterial Vaginosis - Therapeutics under Investigation by Universities/Institutes
  8. Bacterial Vaginosis Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Bacterial Vaginosis - Products under Development by Companies
  13. Bacterial Vaginosis - Products under Investigation by Universities/Institutes
  14. Bacterial Vaginosis - Companies Involved in Therapeutics Development
  • Evofem Inc
  • Osel Inc
  • Starpharma Holdings Ltd
  • Symbiomix Therapeutics LLC

For more information about this report visit http://www.researchandmarkets.com/research/qz8d87/bacterial

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs